The news arrived from the official Weibo account (@华为何刚) of the President of Huawei’s Consumer Business Mobile Phone Product Line. On the Chinese microblogging website, the senior executive stated that the upcoming wearable as passed the medical device registeration test and will be starting with registered clinical trials with professional medical institutions. He further added that the device will be available in the second half of 2021.
Previously, the Chinese tech giant had announced that it had began research into three new health related studies. This inlcudes hypertension management research, smart body temperature health research, and coronary heart disease screening research. So, we can expect the new feature of blood pressure monitoring tying in with these studies as well. Furthermore, this could also lead to improvements and newer features in future wearables from the company.